249420.KS

Ildong Pharmaceutical Co., Ltd. [249420.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

249420.KS Stock Summary

Top 10 Correlated Stocks

249420.KS


In the News

249420.KS Financial details

Company Rating
Buy
Market Cap
471.22B
Income
-79.33B
Revenue
600.76B
Book val./share
6069.76
Cash/share
2909.85
Dividend
-
Dividend %
-
Employees
1.17K
Optionable
No
Shortable
Yes
Earnings
09 Aug 2023
P/E
-3.27
Forward P/E
9.87
PEG
0.95
P/S
0.76
P/B
3.36
P/C
5.41
P/FCF
-5.54
Quick Ratio
-
Current Ratio
0.68
Debt / Equity
1.19
LT Debt / Equity
0.09
-
-
EPS (TTM)
-2.96K
EPS next Y
1596
EPS next Q
-
EPS this Y
-35.37%
EPS next Y
-153.97%
EPS next 5Y
-153.97%
EPS last 5Y
38.88%
Revenue last 5Y
3.03%
Revenue Q/Q
1.04%
EPS Q/Q
-102.96%
-
-
-
-
SMA20
2.31%
SMA50
-1.86%
SMA100
-0.62%
Inst Own
-
Inst Trans
-
ROA
-23%
ROE
-82%
ROC
-0.31%
Gross Margin
36%
Oper. Margin
-12%
Profit Margin
-22%
Payout
-
Shs Outstand
27.93M
Shs Float
16.69M
-
-
-
-
Target Price
-
52W Range
14380.0-24450.0
52W High
-35.58%
52W Low
+9.53%
RSI
46
Rel Volume
1.39
Avg Volume
122.24K
Volume
170.46K
Perf Week
-1.62%
Perf Month
-3.49%
Perf Quarter
-24.64%
Perf Half Y
-24.1%
-
-
-
-
Beta
1.035
-
-
Volatility
401.33%, 326.35%
Prev Close
-1.87%
Price
15750
Change
-3.37%

249420.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
21.75K23.62K23.55K20.26K22.23K
Net income per share
-565.08-547.34-4.25K-4.52K-2.92K
Operating cash flow per share
1.74K814.15-477.87-1.7K-1.35K
Free cash flow per share
925.256.74-1.31K-2.32K-2.03K
Cash per share
3.81K3.62K6.5K2.5K3.01K
Book value per share
10.63K10.7K6.43K6.08K6.27K
Tangible book value per share
7.7K8.05K3.95K4.8K4.89K
Share holders equity per share
10.63K10.7K6.43K6.08K6.27K
Interest debt per share
7.19K7.21K9.95K6.91K7.99K
Market cap
379.51B449.56B799.16B854.38B485.73B
Enterprise value
455.48B530.85B889.73B1009.99B650.31B
P/E ratio
-28.23-34.53-7.91-6.01-6.15
Price to sales ratio
0.730.81.431.340.81
POCF ratio
9.1723.21-70.31-15.96-13.27
PFCF ratio
17.242.81K-25.65-11.68-8.86
P/B Ratio
1.51.775.234.472.86
PTB ratio
1.51.775.234.472.86
EV to sales
0.880.941.591.581.08
Enterprise value over EBITDA
17.0814.86-37.67-23.19-25.91
EV to operating cash flow
11.0127.41-78.28-18.86-17.76
EV to free cash flow
20.693.31K-28.56-13.81-11.87
Earnings yield
-0.04-0.03-0.13-0.17-0.16
Free cash flow yield
0.060-0.04-0.09-0.11
Debt to equity
0.660.661.481.091.19
Debt to assets
0.270.280.320.320.33
Net debt to EBITDA
2.852.28-3.83-3.57-6.56
Current ratio
1.11.260.830.890.75
Interest coverage
-0.241.42-5.15-7.49-3.63
Income quality
-3.08-1.490.110.380.46
Dividend Yield
0.020000
Payout ratio
-0.640000
Sales general and administrative to revenue
0.030.020.020.020.02
Research and developement to revenue
0.090.110.170.170.16
Intangibles to total assets
0.110.10.090.070.07
Capex to operating cash flow
-0.47-0.991.740.370.5
Capex to revenue
-0.04-0.03-0.04-0.03-0.03
Capex to depreciation
-0.69-0.69-0.68-0.66-0.64
Stock based compensation to revenue
00000
Graham number
11.63K11.48K24.78K24.85K20.3K
ROIC
00.02-0.09-0.19-0.12
Return on tangible assets
-0.02-0.02-0.16-0.23-0.14
Graham Net
-7.59K-7.49K-12.85K-8.03K-9.73K
Working capital
21.52B48.23B-62.59B-34.26B-78.55B
Tangible asset value
183.28B191.48B93.96B151.1B132.15B
Net current asset value
-126.46B-117.49B-246.84B-175.55B-201.31B
Invested capital
0.660.661.481.091.19
Average receivables
75.65B63.71B59.03B82.56B85.07B
Average payables
30.17B37.88B37.16B42.22B48.17B
Average inventory
61.47B79.49B85.91B90.42B91.44B
Days sales outstanding
50.5736.2140.6158.8340.92
Days payables outstanding
50.9140.6141.0741.9246.64
Days of inventory on hand
89.29100.6988.4889.3578.55
Receivables turnover
7.2210.088.996.28.92
Payables turnover
7.178.998.898.717.83
Inventory turnover
4.093.624.134.094.65
ROE
-0.05-0.05-0.66-0.74-0.47
Capex per share
-813.5-807.41-832.06-623.01-672.89

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.67K5.46K5.76K5.56K5.41K
Net income per share
-2.02K-404.17-893-1.71K50.69
Operating cash flow per share
-536.75-499.04-529.82-983.9622.78
Free cash flow per share
-759.01-643.27-702.58-1.24K519.49
Cash per share
2.94K2.29K2.03K2.36K2.91K
Book value per share
7.14K6.73K5.83K4.88K6.07K
Tangible book value per share
5.64K5.25K4.38K3.43K4.73K
Share holders equity per share
7.14K6.73K5.83K4.88K6.07K
Interest debt per share
7.86K7.77K8.42K1.56K7.3K
Market cap
727.35B582.32B422.45B564.89B501.94B
Enterprise value
882.95B745.31B605.94B568.63B666.53B
P/E ratio
-3.37-13.45-4.42-3.0788.62
Price to sales ratio
4.793.992.743.783.32
POCF ratio
-50.58-43.58-29.78-21.3428.85
PFCF ratio
-35.77-33.81-22.46-16.9734.59
P/B Ratio
3.83.232.714.32.96
PTB ratio
3.83.232.714.32.96
EV to sales
5.815.13.933.84.41
Enterprise value over EBITDA
-62.4113.7810.8811.41174.32
EV to operating cash flow
-61.4-55.78-42.72-21.4838.32
EV to free cash flow
-43.42-43.28-32.22-17.0845.93
Earnings yield
-0.07-0.02-0.06-0.080
Free cash flow yield
-0.03-0.03-0.04-0.060.03
Debt to equity
1.091.161.420.281.19
Debt to assets
0.320.320.350.060.33
Net debt to EBITDA
-113.013.30.0843.05
Current ratio
0.890.830.780.680.75
Interest coverage
-7.922.9-5.62-3.07-1.07
Income quality
0.271.230.580.5712.29
Dividend Yield
00000
Payout ratio
00-0.0100
Sales general and administrative to revenue
0.020.470.490.450.02
Research and developement to revenue
0.180.170.170.160.13
Intangibles to total assets
0.070.070.070.080.07
Capex to operating cash flow
0.410.290.330.26-0.17
Capex to revenue
-0.04-0.03-0.03-0.05-0.02
Capex to depreciation
-0.76-0.51-0.63-1-0.43
Stock based compensation to revenue
00000
Graham number
17.99K7.82K10.82K13.71K2.63K
ROIC
-0.07-0.03-0.05-0.080
Return on tangible assets
-0.09-0.02-0.04-0.090
Graham Net
-9.43K-9.98K-10.81K-10.39K-9.41K
Working capital
-34.26B-54.86B-77.9B-110.98B-78.55B
Tangible asset value
151.1B140.44B117.14B92.28B132.15B
Net current asset value
-175.55B-187.94B-207.25B-215.14B-201.31B
Invested capital
1.091.161.420.281.19
Average receivables
110.35B102.9B107.46B94.75B72.47B
Average payables
48.17B49.71B49.98B42.72B44.52B
Average inventory
98.97B102.36B107.28B98.9B87.17B
Days sales outstanding
60.8963.4765.3746.6940.12
Days payables outstanding
42.8552.1942.6735.0246.06
Days of inventory on hand
91.32104.2198.8580.9977.56
Receivables turnover
1.481.421.381.932.24
Payables turnover
2.11.722.112.571.95
Inventory turnover
0.990.860.911.111.16
ROE
-0.28-0.06-0.15-0.350.01
Capex per share
-222.26-144.23-172.75-253.42-103.29

249420.KS Frequently Asked Questions

What is Ildong Pharmaceutical Co., Ltd. stock symbol ?

Ildong Pharmaceutical Co., Ltd. is a KR stock and trading under the symbol 249420.KS

What is Ildong Pharmaceutical Co., Ltd. stock quote today ?

Ildong Pharmaceutical Co., Ltd. stock price is $15750 today.

Is Ildong Pharmaceutical Co., Ltd. stock public?

Yes, Ildong Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks